Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Digestive Diseases and Sciences

• Publication date

  2018-03-21

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s10620-018-5025-4PMID 29564669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.

  2017cited by this paper
• Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection

  2017cited by this paper
• Metabolomic approach for improving ethanol stress tolerance in Saccharomyces cerevisiae.

  2016cited by this paper
• Quantification of coffee blends for authentication of Asian palm civet coffee (Kopi Luwak) via metabolomics: A proof of concept.

  2016cited by this paper
• DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function

  2015cited by this paper
• Polyunsaturated fatty acids and inflammation

  2015cited by this paper
• Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission

  2015cited by this paper
• MRM-DIFF: data processing strategy for differential analysis in large scale MRM-based lipidomics studies

  2015cited by this paper
• N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.

  2014cited by this paper
• Supercritical fluid extraction as a preparation method for mass spectrometry of dried blood spots.

  2014cited by this paper
• Metabolome analysis for discovering biomarkers of gastroenterological cancer.

  2014cited by this paper
• Practical evaluation of liquid chromatography/tandem mass spectrometry and enzyme immunoassay method for the accurate quantitative analysis of prostaglandins.

  2014cited by this paper
• Metabolomics for Biomarker Discovery in Gastroenterological Cancer

  2014cited by this paper
• Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.

  2014cited by this paper
• Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view.

  2013cited by this paper
• A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer

  2013cited by this paper
• Development of a lipid profiling system using reverse-phase liquid chromatography coupled to high-resolution mass spectrometry with rapid polarity switching and an automated lipid identification software.

  2013cited by this paper
• A novel serum metabolomics-based diagnostic approach to pancreatic cancer

  2013cited by this paper
• Regulation of the metabolite profile by an APC gene mutation in colorectal cancer

  2012cited by this paper
• L-arginine Supplementation Improves Responses to Injury and Inflammation in Dextran Sulfate Sodium Colitis

  2012cited by this paper
• N-3 PUFAs attenuate ischemia/reperfusion induced intestinal barrier injury by activating I-FABP-PPARγ pathway.

  2012cited by this paper
• Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease

  2012influential reference
• A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer

  2012cited by this paper
• Practical non-targeted gas chromatography/mass spectrometry-based metabolomics platform for metabolic phenotype analysis.

  2011cited by this paper
• GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis

  2011cited by this paper
• GC/MS based metabolomics: development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA)

  2011cited by this paper
• GCMS‐based metabolomic study in mice with colitis induced by dextran sulfate sodium

  2011cited by this paper
• Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature

  2011cited by this paper
• Pyrolysis GC-MS-based metabolite fingerprinting for quality evaluation of commercial Angelica acutiloba roots.

  2010cited by this paper
• Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids.

  2010cited by this paper
• Lipidomic Analysis of Dynamic Eicosanoid Responses during the Induction and Resolution of Lyme Arthritis*

  2009cited by this paper
• Inflammatory bowel disease: clinical aspects and established and evolving therapies

  2007cited by this paper

• 6-Gingerol ameliorates ulcerative colitis by inhibiting ferroptosis based on the integrative analysis of plasma metabolomics and network pharmacology.

  2024cites this paper
• Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment

  2023cites this paper
• Role of metabolites derived from gut microbiota in inflammatory bowel disease

  2022cites this paper
• IMPACT OF STRENGTH AND PLYOMETRIC TRAINING ON AGILITY, ANAEROBIC POWER AND CORE STRENGTH IN BADMINTON PLAYERS

  2021cites this paper
• Differential effects of EPA and DHA on DSS-induced colitis in mice and possible mechanisms involved.

  2021cites this paper
• Proteomic and phospholipidomic characterization of extracellular vesicles inducing tumor microenvironment in Epstein‐Barr virus‐associated lymphomas

  2021cites this paper
• Systematic Metabolic Profiling of Mice with Dextran Sulfate Sodium-Induced Colitis

  2021cites this paper
• SCREENING OF FUNGI FOR PRODUCTION AND PURIFICATION OF OMEGA-3 FATTY ACID

  2021cites this paper
• Fish oil supplementation enhances colon recovery after experimental colitis.

  2020cites this paper
• Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics and Lipidomics Identify Biomarkers for Efficacy Evaluation of Mesalazine in a Dextran Sulfate Sodium-Induced Ulcerative Colitis Mouse Model.

  2020cites this paper
• Metabolomic Analysis of the Liver of a Dextran Sodium Sulfate-Induced Acute Colitis Mouse Model: Implications of the Gut–Liver Connection

  2020cites this paper
• Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease

  2019influential citation
• Omega Fatty Acids and Inflammatory Bowel Diseases: An Overview

  2019cites this paper
• Alterations in Polyunsaturated Fatty Acid Metabolism and Reduced Serum Eicosadienoic Acid Level in Ulcerative Colitis: Is There a Place for Metabolomic Fatty Acid Biomarkers in IBD?

  2018cites this paper